What is YDES's current stock price?

YDES (YD Bio Limited Ordinary Shares) is currently trading at $4.75 with a market cap of $336.4M.

What sector is YD Bio Limited Ordinary Shares in?

YD Bio Limited Ordinary Shares (YDES) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

YDES YD Bio Limited Ordinary Shares

Healthcare

$4.75+3.71%ClosedMarket Cap: $336.4M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-5.67

P/S

0.00

EV/EBITDA

-63.99

DCF Value

$0.12

FCF Yield

-0.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

80.8%

ROA

-37.5%

ROIC

-9.3%

Financials

View All

Period	Revenue	Net Income	EPS
FY null	$596.8K	$-8.3M	$—
Q2 null	$0.00	$-2.2M	$—
Q1 null	$0.00	$-3.4M	$—
Q4 null	$0.00	$417.8K	$—

Trading Activity

Insider Trades

View All

Lu Shao-Tadirector

SellMon Apr 20

Lu Shao-Tadirector

SellThu Apr 02

Lu Shao-Tadirector

SellThu Apr 02

Lu Shao-Tadirector:

SellThu Apr 02

Chang Kochidirector

SellThu Apr 02

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-0.06

Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.

Peers

BTX